Abstract
Abstract
Of the 13 subtypes of Ehlers-Danlos Syndromes (EDSs) identified in the 2017 international classification of EDSs, 12 have a recognized, associated genetic mutation. However, hypermobile EDS (hEDS) currently has no identifiable associated gene. Therefore, patients with hEDS are identified through a set of clinical diagnosis guidelines and criteria, which are meant to differentiate hEDS from other hypermobile joint conditions and other EDSs subtypes. In this article, the authors provide an overview of hEDS symptoms and comborbidities, current treatment options, and the clinical criteria currently guiding the standard of care.
Subject
Complementary and alternative medicine,Complementary and Manual Therapy
Reference20 articles.
1. international classification of the Ehlers-Danlos syndromes;Am J Med Genet C Semin Med Genet,2017
2. Bi-allelic alterations in AEBP1 lead to defective collagen assembly and connective tissue structure resulting in a variant of Ehlers-Danlos syndrome;Am J Hum Genet,2018
3. Ehlers-Danlos syndromes: state of the art on clinical practice guidelines;RMD Open,2018
4. Joint hypermobility handbook: A guide for the issues & management of Ehlers-Danlos syndrome hypermobility type and the hypermobility syndrome.,2010
5. Hypermobile Ehlers-Danlos syndrome (a.k.a;Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet Part C Semin Med Genet,2017
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献